These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 2536930)
1. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir. Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930 [TBL] [Abstract][Full Text] [Related]
2. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87). Spector T; Harrington JA; Porter DJ Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925 [TBL] [Abstract][Full Text] [Related]
3. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir. Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition. Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969 [TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex. Porter DJ; Harrington JA; Spector T Biochem Pharmacol; 1990 Feb; 39(4):639-46. PubMed ID: 2154988 [TBL] [Abstract][Full Text] [Related]
6. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir. Hamzeh FM; Spector T; Lietman PS Antimicrob Agents Chemother; 1993 Mar; 37(3):602-4. PubMed ID: 8384821 [TBL] [Abstract][Full Text] [Related]
8. Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition. Spector T; Stonehuerner JG; Biron KK; Averett DR Biochem Pharmacol; 1987 Dec; 36(24):4341-6. PubMed ID: 2825724 [TBL] [Abstract][Full Text] [Related]
9. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice. Lobe DC; Spector T; Ellis MN Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166 [TBL] [Abstract][Full Text] [Related]
10. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir. Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704 [TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir. Coen DM; Goldstein DJ; Weller SK Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912 [TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy. Prichard MN; Shipman C Chemotherapy; 1995; 41(5):384-95. PubMed ID: 8521741 [TBL] [Abstract][Full Text] [Related]
13. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir. Safrin S; Schacker T; Delehanty J; Hill E; Corey L Antimicrob Agents Chemother; 1993 May; 37(5):975-9. PubMed ID: 8390815 [TBL] [Abstract][Full Text] [Related]
14. Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses. Ellis MN; Lobe DC; Spector T Antimicrob Agents Chemother; 1989 Oct; 33(10):1691-6. PubMed ID: 2556074 [TBL] [Abstract][Full Text] [Related]
15. [Antiviral resistance of herpes simplex virus and varicella-zoster virus]. Daikoku T; Shiraki K Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667 [No Abstract] [Full Text] [Related]
16. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1. Karlsson A; Harmenberg J Antimicrob Agents Chemother; 1988 Jul; 32(7):1100-2. PubMed ID: 2847642 [TBL] [Abstract][Full Text] [Related]
17. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone. Turk SR; Shipman C; Drach JC Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019 [TBL] [Abstract][Full Text] [Related]
19. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. Heineman TC; Cohen JI J Virol; 1994 May; 68(5):3317-23. PubMed ID: 8151792 [TBL] [Abstract][Full Text] [Related]
20. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Morfin F; Frobert E; Thouvenot D Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]